Khosrovi Behzad 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Feb 12, 2009
Insider Transaction Report
Form 4
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2009-01-28+21,300→ 94,200 totalExercise: $1.56From: 2010-01-28Exp: 2019-01-28→ Common Stock (21,300 underlying)
Footnotes (2)
- [F1]Granted pursuant to the NovaBay Pharmaceuticals, Inc. 2007 Omnibus Incentive Plan
- [F2]Twenty-five percent (25%) of the option shares vest and become exercisable upon the first anniversary of the date of grant and thereafter the balance of the option shares vest and become exercisable in a series of twelve (12) equal installments upon the completion of each three (3) months beginning with January 28, 2010.